Tag Archives: COVID19 Vaccine

Gilead’s Remdesivir: Australia approves for COVID 19 Treatment

Australian authority has permitted to use remdesivir for the patient critically suffering from COVID-19 and this is Australia’s coronavirus treatment update

Gilead Sciences First Treatment Option:

The deadly coronavirus which is supposed to be originated in China has engulfed the whole world in its dreadful journey so far and the pace does not seem to slow down. So, the whole world nations are putting their efforts, in finding a solution to stop this COVID-19. Like the whole world, Australia is also making a valiant effort to stop this deadly virus from piling up the casualties. The Australian government has granted permission to the Gilead’s pharmaceutical company for finding Australia COVID-19 treatment. Gilead has been gifted with the first treatment option for coronavirus treatment in Australia. 

Latest Updates:

The latest updates are suggesting that the Australian authority has permitted to use remdesivir for the patient critically suffering from COVID-19 and this is Australia’s coronavirus treatment latest update. It is showing positive symptoms as this medicine is shortening hospital stay and the patients are recovering fast and effectively. 

Remdesivir Vaccine

The TGA has also stated that Remdesivir is a perfect treatment option for seriously infected patients and it has been considered COVID-19 treatment in Australia. Besides they have also confirmed, it has massively reduced the strain from Australia’s healthcare systems because on using it, patients are recovering fast and thus are leaving hospitals early as well. Thus, making it easy for the Australian health ministry. They have also stated that it is available only for the people who are severely infected with COVID-19 and is not freely available for everyone to use. But it is assisting positively Australia coronavirus treatment. At present, it is highly recommended for the patients requiring ventilators to breathe. All in all, it is not commonly used.  

Read: How MMR Vaccine Can Prevention From Worst Symptoms of COVID 19

Proved A Milestone:

Remdesivir usage has been proved beneficial and it won’t be incorrect at all to be called a milestone because it has controlled Australia’s struggle significantly. Though it is not made available freely for everyone still it has managed successfully coronavirus treatment in Australia. While using it for severe cases, it has shown progressive indications that made the Australian Healthcare system happy and cheerful. 

Following the track, the same way from Australia, the European Union, Japan, and Singapore also made their positive enhancement to authorize the use of remdesivir for treating COVID-19. Earlier International regulatory cooperation has made it possible as both the European Medicine Agency and Singapore Health Sciences Authority shared their review reports with TGA Australia. They are also optimistic about the usage of this for treating coronavirus. The TGA has worked day and night in collaboration with Gilead Sciences to confirm the efficacy of the medicine. 

Following Threads:

Gilead Sciences First Treatment Option:

The deadly coronavirus which is supposed to be originated in China has engulfed the whole world in its dreadful journey so far and the pace does not seem to slow down. So, the whole world nations are putting their efforts, in finding a solution to stop this COVID-19. Like the whole world, Australia is also making a valiant effort to stop this deadly virus from piling up the casualties. The Australian government has granted permission to the Gilead’s pharmaceutical company for finding Australia COVID-19 treatment. Gilead has been gifted with the first treatment option for coronavirus treatment in Australia. 

Latest Updates:

The latest updates are suggesting that the Australian authority has permitted to use remdesivir for the patient critically suffering from COVID-19 and this is Australia’s coronavirus treatment latest update. It is showing positive symptoms as this medicine is shortening hospital stay and the patients are recovering fast and effectively. 

The TGA has also stated that Remdesivir is a perfect treatment option for seriously infected patients and it has been considered COVID-19 treatment in Australia. Besides they have also confirmed, it has massively reduced the strain from Australia’s healthcare systems because on using it, patients are recovering fast and thus are leaving hospitals early as well. Thus, making it easy for the Australian health ministry. They have also stated that it is available only for the people who are severely infected with COVID-19 and is not freely available for everyone to use. But it is assisting positively Australia coronavirus treatment. At present, it is highly recommended for the patients requiring ventilators to breathe. All in all, it is not commonly used.  

Proved A Milestone:

Remdesivir usage has been proved beneficial and it won’t be incorrect at all to be called a milestone because it has controlled Australia’s struggle significantly. Though it is not made available freely for everyone still it has managed successfully coronavirus treatment in Australia. While using it for severe cases, it has shown progressive indications that made the Australian Healthcare system happy and cheerful. 

Following the track, the same way from Australia, the European Union, Japan, and Singapore also made their positive enhancement to authorize the use of remdesivir for treating COVID-19. Earlier International regulatory cooperation has made it possible as both the European Medicine Agency and Singapore Health Sciences Authority shared their review reports with TGA Australia. They are also optimistic about the usage of this for treating coronavirus. The TGA has worked day and night in collaboration with Gilead Sciences to confirm the efficacy of the medicine. 

Following Threads:

On the positive note, many countries are opting for remdesivir treatment to tackle COVID-19 in their countries and without any doubt have become their A-one choice after the significant outcome in Australia. It has made Australia COVID-19 treatment way easier and accessible because this intravenously administered medicine has shown positive outcomes during the clinical trials as well and made the treatment fast and effective.  So, continue from here, the US and European Commission have also shown their positive assistance to use this for emergency use. So, the same way trend is following this therapy in Japan, India, Singapore, and the UAE. 

CureVac Started Work For Developing a COVID-19 Vaccine

CureVac AG, the first pharma company in the world using mRNA for medical purposes, is working to develop mRNA-based drugs to cure COVID 19 patients.

Beginning from the first case in China (December 2019), SARS-CoV-2 is severely affecting many countries around the world. In response to the global pandemic, researchers worldwide are using different approaches to develop a coronavirus vaccine at the earliest.

CureVac COVID19 Vaccine

To protect COVID affected patients, CureVac AG is working on the development of mRNA-based drugs for vaccines and therapeutics.

CureVac is a reputed biopharmaceutical company with headquarters in Tubingen, Germany. Founded in 2000, CureVac is the first pharma company in the world that has successfully harnessed mRNA for medical purposes. The company is proud to be part of the international helping hands towards protecting masses from the novel coronavirus. The recent success of the company relates to the Rabies program that aims to fully protect humans with two doses of only one microgram (I millionth of a gram).

The company aims to provide a cost-effective and prophylactic vaccine using unique technology. At present, their team is working on mRNA technology to bring a rapid response to prevent spreading the virus. Since 2007, the company is engaged in the prophylactic vaccine and can produce mRNA vaccines on a colossal scale.

After the Paul Ehrlich Institute, CureVac is the second German company which has begun the trial phase for the vaccine against COVID-19.

To bring practical results and to speed up the development, production, and clinical process, CureVac is in contact with various health organizations such as CEPI (Coalition for Epidemic Preparedness Innovations) and BMGF (Bill and Melinda Gates Foundation.

About mRNA Technology

A natural messenger substance, the vaccine will be a trial to activate the human body against its defence mechanism. With the mRNA technology, it is expected that the human body will recognize the protein of the coronavirus and in response will activate its immune cells to produce antibodies and T-cells against it.

Mariola Fotin-Mleczek (Chief Technology Officer of CureVac) said, “With our unique RNA technology, we prepare the human body how to fight against the virus. Our expertise and disease understanding makes us able to come up with a solution for outbreak solutions like COVID-19.

As per the recent information on the Curevac COVID trial, the company has started human trials after the idea approved by regulators. The first trial by the German biotech firm will involve 168 volunteers, of whom 144 will be given the experimental vaccine.

Many countries are contributing to bringing the coronavirus vaccine. However, projections for how long it will take to develop a vaccine vary widely. Based on the experience and knowledge, researchers need at least a year to come up with an effective solution.

Once researchers successfully create a potential vaccine then brings into the notice of the Food and Drug Administration (FDA) to check its effectiveness.

The next phase is to complete Phase I, Phase II, and Phase III clinical trials to analyze the safety and effectiveness of the drug thoroughly.

The company is expected to begin the next clinical study with several thousand participants in autumn 2020. Even if CureVac remains successful in achieving favourable results, it depends on the regulatory authorities about the availability of the vaccine on the market.

COVID19 Vaccine: Phase-2 Clinical Trials in China

Chinese Academy of Medical Sciences (IMBCAMS) researchers have started the second clinical trial for the COVID19 Vaccine. To know more, read the blog.

COVID-19 has created havoc all over the world. Everyone wants to know when this pandemic is going to end, is there a COVID19 vaccine available that can help curb the spread.

Coronavirus Vaccine News China

Well, currently, no vaccines have proved to be productive work to protect people from this scary virus, but attempts by researchers are going on, and multiple candidates are under progress. About COVID-19 vaccine trials in China, there are five vaccine candidates. Preliminary clinic trial results were positive and expected to test in a Phase 3 trial in Brazil, said by China’s vaccine maker Sinovac Biotech.

As per the Institute of Medical Biology at the Chinese Academy of Medical Sciences (IMBCAMS), Chinese researchers have started the second trial of their potential corona virus vaccine. With several vaccines are in different stages of tests globally, none of the trials have passed large-scale. The phase-2 human test is one of the six vaccines that Chinese researchers are developing against the corona virus. The first phase held in May recruited around 200 individuals to participate in the test. Phase-2 COVID19 Vaccine trials in China will emphasize the immune responses while determining the shot’s dose. This year, China expected to use a plant to produce a corona virus vaccine to meet China’s future vaccine supplies. By the end of 2020, people with special needs may use experimental vaccines under urgent circumstances, by Gao Fu (Director at the Chinese Center for Disease Control and Prevention). As per China National Biotec Group and UAE state media, China and The United Arab Emirates have launched a Phase 3 Clinical trial of a COVID-19 Vaccine China.

On June 24, 2020, this trial agreement was signed between the two countries by the G42 and the Sinopharm Group, a leading research-based pharmaceutical company and affiliate of CNBG. This collaboration is not the only vaccine at the phase 3 stage, but also the University of Oxford has begun a phase 3 trials on its vaccine with 30, 000 participants in July.

Globally, the researchers are putting efforts to find a corona virus vaccine. However, it is still unsure whether a vaccine will be available to the public, but there is a hope to produce it by early 2021.

Vaccines undergo multiple phase trials to ensure effectiveness and safety. According to the US Centers for Disease Control and Prevention, clinical development takes three phases. Phase 1 includes small groups of people to get the trial vaccine. A larger group with people having similar characteristics is involved in the phase 2 trial. A phase 3 trial can be a critical moment which may use to confirm results from phase and phase 2 vaccine trials.

The report by the World Health Organization reveals that there are 16 candidate vaccines in clinical evaluation and a further 125 in preclinical evaluation.

And while scientists and researchers are in a battle to win the COVID19 Vaccine, there is still no guarantee of how and when one will find.